caNanoLab
LizzyN edited this page Oct 22, 2023
·
1 revision
The cancer Nanotechnology Laboratory (caNanoLab) portal facilitates the secure exchange of these characterizations and related nanotechnology processes, as well as the annotation of nanomaterials with characterizations derived from physico-chemical, in vitro, and in vivo experiments. To speed up and confirm the application of nanotechnology in biomedicine, caNanoLab is a data sharing platform created to facilitate information sharing within the global community of biomedical nanotechnology researchers.
- Microenvironment-triggered multimodal precision diagnostics
- Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications
- Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery
- Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy
- Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticle
- Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points
- STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
- Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles
- Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced Iodine-125 seed brachytherapy for esophageal cancer
- Silver Nanoparticles as Carriers of Anticancer Drugs for Efficient Target Treatment of Cancer Cells
More information about caNanoLab can be found at https://cananolab.cancer.gov/#/